Oral Health Outcomes with GLP1 Receptor Agonists Compared with Other Metabolic Interventions
Preprints.org
Abstract
Semaglutide and tirzepatide are increasingly used for obesity and diabetes, producing substantial changes in appetite, dietary intake, body weight, glycemic control, and gastrointestinal physiology that could plausibly influence oral health.
The paper
Marwaha A, Murugadoss K, Venkatakrishnan A et al.
Preprints.org · 24 Aug 2026 · CC BY · Preprint, not peer-reviewed